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The draining LNs (DLNs) are dynamic lym-
phoid structures that coordinate the development 
of specific immune responses after microbial 
or vaccine challenge. In response to these periph-
eral events, the DLN quickly undergoes signifi-
cant structural changes, including rapid growth 
and vascular remodeling (McLachlan et al., 
2003; Soderberg et al., 2005). This enlargement, 
which is largely attributable to enhanced re-
cruitment and retention of naive lymphocytes 
from the circulation, increases the probability 
that rare lymphocytes bearing relevant specifici-
ties will be present to interact with activated tis-
sue-derived APCs, which must migrate from 
inflamed tissues via afferent lymphatic vessels. 
This interaction between lymphocytes and 
APCs occurring within DLNs is the critical ini-
tiating event in the development of the adaptive 
immune response.
For these rapid and impressive changes in 
DLNs to occur after microbial or vaccine chal-
lenge, not only should lymphocytes and APCs 
be  able  to  reach  the  DLN  but,  importantly, 
LNs must receive signals from the periphery to 
create the appropriate environment to facilitate 
this interaction. It has been suggested that the 
periphery signals the DLN by “remote control” 
(Baekkevold et al., 2001; Palframan et al., 2001; 
Huang et al., 2008). For example, a chemokine, 
monocyte chemoattractant protein-1, has been 
suggested to drain via afferent lymphatics into 
the DLN (Palframan et al., 2001). A potential 
peripheral source of immunomodulatory medi-
ators is the mast cell (MC), a cell type which is 
strategically situated beneath epithelial barriers. 
In addition to their presence at potential sites of 
pathogen entry, MCs express numerous pattern 
recognition and other receptors for rapidly 
recognizing pathogens (Prodeus et al., 1997; 
Malaviya et al., 1999; Supajatura et al., 2001), as 
well as the capacity to release large amounts of 
inflammatory mediators, many of which are 
concentrated within prominent cytoplasmic 
granules and are available for immediate release. 
One such prestored mediator is TNF (Gordon 
and Galli, 1990), a multifunctional cytokine 
which is implicated in modulating immune cell 
trafficking. Recent studies have shown that as 
rapidly as 1 h after peripheral MC activation, 
increased levels of TNF are detected in pre-
nodal lymph (Frangogiannis et al., 1998) and in 
the DLNs (McLachlan et al., 2003). The lack of 
any corresponding change in DLN TNF mes-
sage suggested that it was not newly synthesized 
locally but was derived from peripheral sources 
(McLachlan et al., 2003). Because a significant 
period of time is required for the secretion of 
de novo cytokine after stimulation, this peripheral 
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During infection, signals from the periphery are known to reach draining lymph nodes 
(DLNs), but how these molecules, such as inflammatory cytokines, traverse the significant 
distances involved without dilution or degradation remains unclear. We show that peripheral 
mast cells, upon activation, release stable submicrometer heparin-based particles containing 
tumor necrosis factor and other proteins. These complexes enter lymphatic vessels and 
rapidly traffic to the DLNs. This physiological drug delivery system facilitates communication 
between peripheral sites of inflammation and remote secondary lymphoid tissues.
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Video microscopy of these events revealed the dynamics of 
particle  release  by  MCs  (Video  1).  Interestingly,  particles 
were released relatively gradually and continued to be shed 
for at least a minute after treatment.
To demonstrate the release of particles by MCs in vivo, 
we injected the footpads of mice with compound 48/80 and, 
30 min later, thin tissue sections were prepared and examined 
for MC granule release. The granules were detected with Alexa 
Fluor 488–conjugated avidin, a probe which selectively binds 
heparin (Tharp et al., 1985), a major constituent of MC gran-
ules (Fig. 1, D and E). Also, when MCs were activated in vivo 
with another more physiological stimulus, bacterial peptido-
glycan, identical particles were released into the surrounding 
tissue (unpublished data). This is consistent with the work of 
others showing that the morphology of degranulation is not 
highly dependent on the stimulus (Bloom and Chakravarty, 
1970; Tizard and Holmes, 1974). Significant MC degranu-
lation was observed in the footpad sections and extracellular 
particles moved significant distances from their parent cells, 
especially in areas of less dense connective tissue. Observations 
revealed that 30 min after MC degranulation in vivo, mor-
phologically distinct particles containing heparin could be 
detectable in the immediate vicinity as well as at considerable 
distances (up to 150 µm in this section) from the site of release. 
Some of these extracellular particles were still detectable up to 
one hour after treatment (unpublished data).
Next, we attempted to determine whether relevant sig-
naling molecules were present in the particles released by 
MCs. Recent evidence shows that TNF, like many other 
immune molecules, binds to heparin (Kenig et al., 2008), 
suggesting that it may be retained in the heparin-based parti-
cles after exocytosis. To investigate this, we purified MC 
granule particles from rat peritoneal lavage cells using a modi-
fication of a previously described technique (Lindstedt et al., 
1992). In brief, the cells were treated with compound 48/80 
and the released particles were isolated by differential centrif-
ugation. Fig. 2 A shows a micrograph of a suspension of iso-
lated MC-derived particles. The purified particles were very 
stable after isolation, not changing appreciably in appearance 
or protein composition even after 2 mo at room temperature. 
To determine their bulk protein composition, we subjected 
them to SDS-PAGE followed by SYPRO Ruby staining 
(Fig. 2 B). The major bands between 25 and 37 kD corre-
spond to the major rat MC proteases, as determined by a 
proteomic analysis (unpublished data), which are known to 
be the most abundant protein constituents of MC granules 
(Lagunoff and Pritzl, 1976). We also used these preparations 
to address whether signaling molecules, such as TNF, are 
present in the particles as minor components. Because TNF 
was shown in earlier studies to be relevant to morphological 
changes in the DLNs (McLachlan et al., 2003), we were espe-
cially interested in the presence of this signaling molecule. An 
anti-TNF immunoblot of purified granule remnant proteins 
revealed a band that comigrated with recombinant rat TNF 
(Fig. 2 C). The identity of this band was confirmed with two 
additional different anti-TNF antibodies (unpublished data). 
source appears to be preformed MC TNF, a conclusion sup-
ported by the finding that most MCs in the vicinity of infec-
tion were degranulated (McLachlan et al., 2003). One might 
presume that TNF, secreted by peripheral MCs into the extra-
cellular fluid, enters lymphatic vessels and then is carried to 
DLNs as a soluble molecule in the lymph. However, consid-
ering the route of trafficking and the significant distances 
involved, it is unclear how peripherally derived TNF could 
reach the DLNs without degradation, dilution to ineffective 
concentrations, or interaction with extracellular matrix com-
ponents. This scenario is especially difficult to rationalize early 
in the response when it is expected that only small amounts of 
TNF are elaborated, and because TNF has a very short half-
life in vivo (Rampart et al., 1989). This uncertainty is sup-
ported by the observation that although peripherally injected 
chemokines can be detected in DLNs, it typically requires the 
application of large quantities of recombinant protein (Stein 
et al., 2000; Baekkevold et al., 2001).
One conceivable explanation for the long-distance action 
of MC-derived TNF is its trafficking in a form resistant to 
dilution and degradation. To investigate this possibility, we 
examined the process of MC exocytosis in detail. When MCs 
undergo secretory exocytosis of granules (degranulation), in 
addition to releasing some prestored mediators as freely solu-
ble molecules (e.g., histamine and -hexosaminidase), they 
also release distinct insoluble granular particles, comprised 
primarily of heparin proteoglycans and positively charged 
proteases (Schwartz et al., 1981). Other than isolated studies 
describing their uptake by phagocytic cells (Welsh and Geer, 
1959; Miyata and Takaya, 1985), the fate of these particles 
after  MC  degranulation  is  largely  unknown.  MC  granule 
particles are insoluble because of the large numbers of elec-
trostatic interactions between the highly cationic MC-specific 
proteases and highly anionic heparin proteoglycans (Schwartz 
et al., 1981). Because heparin is also known to bind strongly 
to a variety of extracellular signaling proteins (Roberts et al., 
1988; Webb et al., 1993), it is probable that some MC-derived 
mediators are borne within the particle structure even after 
their release. This possibility led us to hypothesize that MC 
particles might function as extracellular chaperones for MC 
mediators (e.g., TNF) in vivo, carrying these signaling mole-
cules from the periphery to the DLN.
RESULTS
Activated MCs release stable particles containing 
inflammatory mediators
First, we investigated whether MCs released stable particles 
upon activation. Fig. 1 (A and B) shows scanning electron 
micrographs (SEMs) of isolated rat peritoneal MCs before 
and after 15 min of exposure to compound 48/80, a potent 
small molecule MC activator. After MC activation, a large 
number of extracellular spherical particles were dispersed 
around each MC (Fig. 1 B), which had a mean diameter of 
917 nm. Examination at higher magnification revealed that 
each of these particles was comprised of many smaller, mostly 
spherical, subunits with a mean diameter of 59.4 nm (Fig. 1 C). JEM VOL. 206, October 26, 2009 
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Figure 1.  MCs release insoluble heparin-containing particles. (A) SEM of an unstimulated rat peritoneal MC (rPMC). Bar, 2 µm. (B) SEM of rPMC  
15 min after treatment with compound 48/80 at 5 µg/ml. Bar, 2 µm. (C) SEM of a single extracellular granule. Bar, 500 nm. Release of particles by rat perito-
neal MCs was observed repeatedly (in greater than three independent experiments). SEMs are shown from one representative experiment. For some trials  
(A–C), lavage was pooled from multiple rats to obtain sufficient material for analysis. (D) Confocal micrograph of MCs in mouse footpad (granule heparin 
labeled with Alexa Fluor 488–conjugated avidin) 30 min after PBS injection showing undegranulated MCs. Bar, 30 µm. (E) Mouse footpad MCs surrounded by 
extracellular particles 30 min after injection of 5 µg of compound 48/80. Bar, 30 µm. Release of particles in vivo was observed in greater than three indepen-
dent experiments using groups of two to three mice each. Experiments are representative of data derived from greater than three animals.2458 MAST CELL PARTICLES DELIVER SIGNALS TO LYMPH NODES | Kunder et al.
Figure 2.  MC-derived particles contain preformed TNF. (A) Differential interference contrast micrograph of purified MC granule particles. (B) SYPRO 
Ruby–stained SDS-PAGE gel of MC particle-associated proteins. (C) TNF immunoblot of SDS-PAGE–separated proteins from purified particles showing 
detection of rat TNF. (D) A still image from Video 2 showing that particles released from RBL-2H3 cells after activation retain overexpressed TNF-GFP 
fusion protein. Bars, 15 µm. White boxes highlight released particles with retained fluorescence. All panels depict data representative of experiments 
performed more than three times, with trials using lavage from individual rats or pooled from multiple rats, for a total n > 3.JEM VOL. 206, October 26, 2009 
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To further demonstrate the presence of TNF within released 
MC-derived particles, we expressed a TNF-GFP fusion pro-
tein in the rat MC line RBL-2H3 and in mouse BM-derived 
MCs (BMMCs) to follow the extracellular fate of preformed 
TNF after degranulation. In both cases, the fusion protein 
was clearly localized to vesicles, and it colocalized with 
known granule markers (Fig. S1). After activation, both cell 
types released free particles that retained their fluorescence 
in the extracellular environment (Fig. 2 D and  Videos   
2 and 3). Although the particles released by the cells have not 
been biochemically characterized, their origin in the gran-
ular compartment suggests that they are similar in nature to 
those released by peritoneal MCs. These findings strongly 
suggest that TNF released from activated MCs is not freely 
soluble but remains associated with the granular heparin 
matrix after exocytosis.
MC-derived particles drain to local LNs via lymphatics
In order for MC-derived particles to reach the DLN, they 
must be able to enter lymphatic vessels. Unlike the vascular 
endothelium, the endothelium of lymphatic capillaries is 
highly permeable as a result of the presence of discontinuities 
between individual endothelial cells. These gaps can be larger 
than a micrometer in diameter and should readily admit ob-
jects the size of MC-derived particles (Leak, 1980; Trzewik 
et al., 2001). Indeed, during edema (which occurs almost in-
stantaneously after MC degranulation because of the rapid 
action of the completely soluble mediator histamine on vas-
cular permeability), these openings are enlarged as the rela-
tive quantity of bulk tissue flow entering the lymphatic system 
is greatly increased (Casley-Smith, 1980). Thus, it is likely 
that conditions in the tissue after MC activation favor the entry 
of these particles into lymphatic vessels.
To visualize this process, we focused on the rat mesen-
tery, because it was amenable to observation in whole mount, 
allowing the entire lymphatic network and connective tissue 
drainage to be visualized (Fig. 3 A). In mesentery isolated 
30 min after the intraperitoneal instillation of compound 48/80, 
extensive MC degranulation occurred, and clear colocaliza-
tion between extracellular MC granule particles and lym-
phatic capillaries was observed along the length of lymphatic 
vessels (Fig. 3, B and C). In contrast, there was little to no 
degranulation in untreated rat mesentery (Fig. S2). Close ex-
amination of lymphatic vessels in compound 48/80-treated 
rats, such as the area proximal to the two degranulated MCs 
shown in Fig. 3 (D and F), revealed that MC particles appear 
frequently in the center of the vessel surrounded entirely by 
staining for lymphatic markers. However, because the lym-
phatic vessels in these preparations are collapsed, it was not 
possible to definitively demonstrate the presence of the parti-
cles within them, although it is unlikely that there is much 
space outside the vessels given the extreme thinness of the 
tissue (15–20 µm; Barber et al., 1987). So, to corroborate 
these data with cross-sectioned patent lymphatic vessels, we 
returned to the mouse footpad. Dilated lymphatics were fre-
quently seen in this tissue 30 min after the injection of com-
pound 48/80. We clearly observed MC-derived particles on 
the luminal side of the endothelium (Fig. 3 G; Videos 4 and 5 
show 3D reconstructions of this area imaged with laser-
scanning confocal microscopy). DIC microscopy of the same 
area revealed that the particle shown in Fig. 3 G was not 
inside a migrating phagocyte but was apparently moving as a 
free particle (Fig. S3). Together, these images suggest that 
MC-derived particles can gain access to and traffic within the 
lymphatic system.
Next, we sought to demonstrate that the MC particles 
could reach DLNs from the periphery. Our initial attempts to 
detect MC particles trafficking from footpads to DLNs was 
confounded by the fact that the MC activator compound 
48/80 that we had injected not only activated tissue resident 
MCs but had also drained into the DLNs, causing degranula-
tion of LN-resident MCs (Fig. 4 A). Therefore, we selectively 
activated peripheral MCs in the skin by painting the footpads 
with a solution PMA in acetone (Wershil et al., 1988). In 
agreement with the literature, this treatment caused local 
degranulation. Footpad MCs were intact after painting with 
acetone alone. Next, we examined the DLNs to see if the 
observed MC degranulation was selective to the site of appli-
cation. In contrast to DLNs harvested 2 h after administration 
of compound 48/80, where extensive degranulation of LN 
MCs occurred (Fig. 4 A), the LN-resident MCs of mice after 
PMA treatment (Fig. 4 C) appeared similar to vehicle alone 
(Fig. 4 B), without apparent degranulation. Having confirmed 
that the topical application of PMA selectively activated foot-
pad MCs, we examined the DLNs more closely and observed 
numerous metachromatic (heparin containing) particles in the 
periphery of the same LN section shown in Fig. 4 C (Fig. 4 D). 
The subcapsular and cortical sinuses, also at the edge of the 
LN, are the first to receive peripheral lymph from afferent 
lymphatics. A higher magnification of a selected area of the 
DLN shows several individual particles (Fig. 4 E).
To support our conclusion that particles detected in the 
DLNs originated from the periphery and to determine with 
certainty that these particles could traffic from peripheral sites 
to the DLN, we isolated particles from the peritoneal MCs of 
mice. These particles were injected into the footpads of MC 
deficient KitW-sh/W-sh mice. DLNs were isolated 45 min later 
and cross sections were examined for the presence of granules 
after toluidine blue staining. At this early time point, it was 
extremely unlikely that the observed particles were delivered 
to the LN inside migrating cells, as the processes involved in 
migrating through tissues and across the lymphatic endothe-
lium are complex and require changes in gene expression. 
Distinct particles appeared to be widely distributed in the 
cortical and medullary sinuses of the DLNs (Fig. 5, A and B). 
A close-up showing a cluster of metachromatic particles in 
the periphery of the DLN is shown in Fig. 5 C. To exclude 
the possibility that particles of this size only enter lymphatic 
vessels under conditions of nonphysiologic interstitial pres-
sure (as a result of injection), we painted a footpad laceration 
with a suspension of fluorescent microspheres with the same 
size and surface charge characteristics of MC-derived particles. 2460 MAST CELL PARTICLES DELIVER SIGNALS TO LYMPH NODES | Kunder et al.
Figure 3.  Extracellular MC granule particles enter lymphatic capillaries. (A) Mosaic of 40× confocal micrographs showing association of MCs and 
lymphatic capillaries in whole mount rat mesentery preparation. Inset, 5× magnified view of (A). Green, LYVE-1; blue, MC heparin. Bar, 1 mm. (B) Fluores-
cence micrograph showing colocalization between released MC-derived particles and lymphatic capillaries 30 min after intraperitoneal injection of 500 µg of 
compound 48/80. Green, LYVE-1; red, MC heparin. Bar, 25 µm. (C) Same area as in B, but only areas of colocalization are shown. (D–F) Confocal micro-
graphs of MC granule particles inside a lymphatic capillary in rat mesentery whole mount 30 min after intraperitoneal injection of 500 µg of compound 
48/80. D, anti-LYVE-1; E, avidin; F, overlay. Green, LYVE-1, blue, MC heparin. Bars, 20 µm. (G) Isosurface rendering of confocal volume from mouse footpad 
section 30 min after injection of compound 48/80. Green, LYVE-1; blue, MC heparin. Bar, 8 µm. All images are representative of experiments repeated 
independently at least twice. Three rats were used for intraperitoneal compound 48/80 studies, and several groups of two to three mice were used for 
footpad compound 48/80 studies.JEM VOL. 206, October 26, 2009 
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Figure 4.  Topical application of PMA activates only local MCs, allowing visualization of trafficked granules in the DLN. (A–C) Toludine blue–
stained sections of DLN tissue 2 h after injection with 32 µg of compound 48/80 (A), topical application of vehicle alone (B), or topical application of  
10 µg PMA (C). (D and E) Free metachromatic granules could be visualized within the DLNs of PMA-treated footpads. E is the magnified view of the white 
box in D. All panels show results that are representative of three independent experiments using groups of 2–3 mice each. Bars: (A–D) 50 µm; (E) 20 µm.
Microspheres were found in the DLN only 30 min later, 
indicating that they entered lymphatic vessels and were deliv-
ered by lymph (Fig. S4). Collectively, these experiments 
indicate that MC particles readily traffic to the DLNs via the 
lymphatic system.
Particle-associated TNF elicits LN enlargement
Our hypothesis is that peripheral MCs are able to modulate 
important physiological activities at distal sites through the 
release of particles bearing critical mediators. Therefore, we 
examined the effect of footpad injection of MC particles on 
LN remodeling. To demonstrate the specific contribution of 
TNF, we injected an equal number of particles isolated from 
TNF/ mice in a parallel experiment. The LN hypertrophy 
induced by granules from WT and TNF/ animals was 
compared after 24 h to saline-injected controls. Although 
MC particles from wild-type mice induced a twofold increase 
in LN size, particles from TNF/ mice failed to trigger any 
LN hypertrophy (Fig. 5 D). This finding not only demon-
strates a functional role for MC-derived particles but also 
demonstrates the specific role played by TNF bound within 
them in modulating LN hypertrophy.
Another important component of our hypothesis is that 
by being packaged within stable particles, MC mediators, 
such as TNF, should be protected from dilution and degrada-
tion and that, therefore, minimal amounts will be required to 
promote biological activity at their target sites. To test this 
notion, we compared soluble recombinant TNF to TNF en-
capsulated within synthetic heparin/chitosan particles for 
their ability to effect remodeling of DLNs. As mentioned 
previously, heparin has a very high negative charge density. 
Chitosan, in contrast, is a polycation at pH <5.5 because of 
protonation of the amino groups in the side chains of the 
polysaccharide. When solutions containing these compounds 
are mixed, they rapidly phase separate to form spherical par-
ticles because of electrostatic interaction of the oppositely 
charged heparin and chitosan. This same process, called poly-
electrolyte complexation, is thought to be the mechanism by 
which insoluble complexes are formed in MC granules, only 
with highly basic MC proteases substituting for chitosan as 
the polycation (Schwartz et al., 1981). The resulting particles 
were similar in size to those purified from rat MCs (Fig. 6, 
A and B). Because any molecules bound to heparin or chitosan 
before the mixing can be packaged within, we encapsulated 2462 MAST CELL PARTICLES DELIVER SIGNALS TO LYMPH NODES | Kunder et al.
In addition, microparticles fabricated in exactly the same way 
except for the omission of TNF did not cause LN enlarge-
ment (Fig. 6 C), showing that TNF, and not the delivery 
vehicle, was responsible for the observed effects. Likewise, 
the injection of a mixture of the soluble components (com-
bined under pH conditions under which no particles form) 
was not adequate to elicit LN enlargement (Fig. 6 C). Col-
lectively, these findings reveal that, when packaged within 
particles of similar composition as MC particles, minimal 
amounts of TNF applied in the periphery can induce signifi-
cant remodeling of distal DLNs.
DISCUSSION
In conclusion, we have demonstrated the existence of a novel 
form of extracellular communication over long distances. The 
use of the circulatory system to deliver extracellular signals 
recombinant TNF (rTNF) in synthetic particles by adding 
the mediator to the heparin solution before complexation.
As shown in Fig. 6 C, the delivery of TNF in particle 
form increased its potency for causing LN enlargement by 
>10-fold. As the amount of TNF encapsulated was not directly 
measured, the 1-ng dose shown assumes 100% encapsulation. 
Other experiments performed during the development of 
these particles suggest that the true level of encapsulation 
using this protocol is almost never >30% (unpublished data), 
indicating that the 10-fold difference in potency between 
particle-delivered TNF and soluble TNF is a significant un-
derestimate. In a separate experiment, we observed that even 
as little as 16 pg of TNF could elicit LN hypertrophy when 
delivered in particle form, supporting previous findings that 
the early increases in DLN TNF reflect the movement of 
a very small amount of cytokine (McLachlan et al., 2003). 
Figure 5.  Injected granules traffic to the DLN and contain functional TNF. (A) Toluidine blue staining of DLN tissue sections from an MC-deficient 
KitW-sh/W-sh mouse injected with 9.0 × 103 isolated MC-derived particles. Bar, 50 µm. (B) Same area as in A showing only metachromatic staining. The loca-
tion of the edge of the DLN is depicted by a dashed line. (C) Magnification from square in A. Bar, 10 µm. (D) LN hypertrophy 24 h after injection of 1.5 × 104 
particles purified from WT or TNF/ mice (n = 3 for each group; *, P < 0.005 for the comparison between the two groups; data analyzed by unpaired two-
tailed Student’s t test; error bars indicate standard error of the mean). All panels show results that are representative of two independent experiments.JEM VOL. 206, October 26, 2009 
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large populations of cells devoted to that purpose. This kind 
of signaling is relatively untargeted, insofar as high enough 
concentrations are reached in the circulation that the soluble 
mediator can be detected easily by most cells in the body or 
at least by a receptor-bearing subset. Endocrine signaling is 
is well known, as endocrine signaling involves the transport 
of hormones from their secreting cells to distant targets. 
However, this has mainly been studied in the context of sig-
nals that reach easily measurable concentrations. Such hor-
mones, such as insulin, are secreted in great quantities by 
Figure 6.  Encapsulation in heparin/chitosan particles greatly enhances the ability of recombinant TNF to effect popliteal LN enlargement 
24 h after footpad injection. (A) DIC micrograph showing purified rat MC-derived particles. (B) Micrograph showing synthetic heparin/chitosan 
microparticles. These micrographs are representative of more than three independent experiments. Bars, 10 µm. (C) Less than 1 ng rTNF encapsulated in 
1.3 × 105 synthetic particles similar to MC granule particles elicits more LN enlargement than 10 ng of soluble TNF when injected into the footpads of 
mice. Black bars, particles with and without encapsulated TNF; open bars, soluble TNF; hatched bar, soluble TNF mixed with soluble chitosan and heparin 
(n = 3 for each group; *, P < 0.05 vs. 10 ng soluble TNF; **, P < 0.01 vs. particles without TNF, 1 ng soluble TNF, and 1 ng soluble TNF mixed with soluble 
chitosan and heparin; data analyzed by one-way analysis of variance followed by Tukey’s Multiple Comparisons test; error bars indicate standard error of 
the mean). Results shown are representative of two independent experiments.2464 MAST CELL PARTICLES DELIVER SIGNALS TO LYMPH NODES | Kunder et al.
reach the node remains to be elucidated. The most obvious 
target of peripheral TNF in the LN is the high endothelial 
venule (HEV) endothelium, which controls the recruitment 
of naive lymphocytes from the circulation into the node   
(a critical determinant of LN size). The up-regulation of adhe-
sion molecules here could enhance such recruitment, and that 
does appear to be an aspect of MC-dependent LN enlarge-
ment (McLachlan et al., 2003). It is known that small soluble 
molecules can reach this site from afferent lymph via conduits 
that connect the sinus system to the HEV (Gretz et al., 2000). 
The size of the MC particles precludes their entry into this 
conduit system. We favor a mechanism by which cargo mol-
ecules are solubilized over time, essentially acting as slow-
release capsules allowing the persistence of the signal until it 
has been carried most of the way to its target. Supporting this 
notion, experiments performed during the development of 
the synthetic microparticles described here showed that such 
particles do release encapsulated TNF over the course of 24 h 
(Fig. S5), suggesting that this may be the case. Alternatively, 
the site of action may be in the sinus system, and an amplifi-
cation step may be required before the signal can be propa-
gated to the HEVs. It is also likely that processes other than 
lymphocyte recruitment (such as prevention of lymphocyte 
egress) are also affected.
It is interesting to speculate that this process also occurs in 
human biology, where the distances between peripheral sites 
of infection or inflammation and draining secondary lym-
phoid tissue are even greater, presumably increasing the 
necessity of an adaptation such as the one described in this 
paper. Although there are substantial differences between human 
and rodent MCs, human MCs do contain preformed TNF 
(Walsh et al., 1991; Frangogiannis et al., 1998). There is also 
significant evidence to suggest that human MCs also release 
insoluble granule contents during degranulation (Kobayasi 
and Asboe-Hansen, 1969; Murphy et al., 1987; Caulfield 
et al., 1990; Kaminer et al., 1991; Lee and Vijayasingam, 
1995; Akimoto et al., 1998). Given these factors, it is proba-
ble that a similar system operates in human immunology.
MCs reside at the crossroads between the external envi-
ronment, the blood vasculature, and the lymphatic system. 
They are ideally situated to orchestrate events during the ear-
liest stages of immune responses, and it seems likely that this 
is their physiological role in mammalian biology. In fact, their 
proximity to these critical structures suggests that they influ-
ence them directly in many ways in addition to those that 
have already been described. This work indicates one way in 
which these important cells may also influence events in distant 
lymphoid tissues.
Finally, many other immune cells including neutrophils 
(Niemann et al., 2007), eosinophils (Erjefält et al., 1999), ba-
sophils (Metcalfe et al., 1984), and cytotoxic T lymphocytes 
(Masson et al., 1990) store biologically active compounds in 
granules. The granular matrix in these cell types is comprised 
of serglycin proteoglycans, which, in addition to their role in 
storage, can contribute to the extracellular function of the 
bound mediators (Veugelers et al., 2004). To date, only the 
also important during immunological responses, for example, 
the induction of the systemic acute phase response after initi-
ation of inflammation (Suffredini et al., 1999).
This work suggests that there may exist a much less obvi-
ous, but equally important, parallel secondary system of long 
distance inflammatory communication earlier in responses, 
involving much lower levels of signals. Because most inflam-
matory signals are not very long lived, it is reasonable to expect 
that adaptations must have developed to prolong the survival 
of extracellular signals and to ensure their delivery to specific 
targets. This kind of adaptation is already well known for 
many blood-borne endocrine signals whose solubility and 
targeting are regulated by serum carrier proteins (Bischoff 
and Pilhorn, 1948; Gordon et al., 1952). The delivery of 
TNF to DLNs during inflammation by MC-derived particles 
appears to provide an example of such an adaptation. As op-
posed to the kind of untargeted signaling discussed previ-
ously, MC particles seem to be specialized for the delivery of 
very small quantities of cargo from one specific site (the site 
of inflammation) to another specific site (targets in the DLN 
that can mediate changes favoring the development of adap-
tive immunity). Heparin, the predominant component of 
MC particles, has the highest negative charge density of any 
molecule known in mammalian biology, which likely mini-
mizes interaction with adjacent cells and other structures in 
the extracellular environment, with this charge favoring their 
movement into the lymphatic drainage (Patel et al., 1984). In 
contrast, their size (although likely retarding their movement 
through peripheral tissues) would also prevent them from 
moving through the DLN to the efferent lymph, resulting in 
their sequestration in this target organ (Hirano and Hunt, 
1985). This scenario is favored by our finding that packaging 
TNF in similar heparin-based synthetic particles greatly 
enhances its potency relative to soluble TNF.
Synchronization and collaboration between the periphery 
and the draining secondary lymphoid tissue is crucial for a rapid 
and effective host response to infection. DLN enlargement 
alone can shorten the time between pathogen entry and anti-
gen presentation by increasing the chances that the extremely 
rare circulating lymphocytes carrying receptors for antigens 
specific to the infection are present. The delivery of inflamma-
tory signals by this unusual mechanism may help to explain 
how this MC-dependent process occurs so rapidly given the 
small amount of prestored cytokine available. It is also possible 
that particle-associated molecules other than TNF might be 
important in aspects of LN remodeling; MC proteases are 
clearly present in large quantities, and other low-abundance 
signaling molecules may also be present. For example, there is 
some evidence that MCs also prestore fibroblast growth factor 2 
(Qu et al., 1998) and vascular endothelial growth factor 
(Grützkau  et  al.,  1998),  two  well  known  heparin-binding 
growth factors which could be involved in the regulation of 
LN vascular remodeling during immune responses.
Although the work presented in this paper demonstrates 
that MC-derived particles can deliver signals from the pe-
riphery to LNs, the disposition of such signals once they JEM VOL. 206, October 26, 2009 
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Microscopy.  Whole  mount  rat  mesentery  preparations  were  made  by 
stretching a loop of bowel over a slide so that the transparent windows were 
spread across them, waiting for these to dry, and then cutting away un-
wanted tissue. Then they were fixed with cold acetone, permeabilized, and 
blocked overnight in PBS with 0.3% Triton X-100 and 5% goat serum, and 
labeled with an anti–LYVE-1 antibody (Millipore) and fluorophore (Alexa 
Fluor 488 or TRITC, depending on the experiment)-labeled avidin (Sigma-
Aldrich) before imaging using a laser-scanning confocal microscope. The 
LYVE-1 antibody was detected with an FITC-conjugated anti–rabbit IgG 
F(ab)2 (Jackson ImmunoResearch Laboratories). Some images were made 
under epifluorescence illumination.
For sections, 10-µm frozen sections were made and fixed in cold ace-
tone before being blocked in PBS with 1% BSA and subsequently labeled 
with the reagents described in the previous paragraph. For toluidine blue 
staining, frozen sections were rapidly fixed in 75% methanol, 20% formalde-
hyde, and 5% acetic acid and then stained in acidic 0.1% toluidine blue and 
cover slipped.
To create the image showing only metachromatic areas of toluidine 
blue–stained LN sections, the original image was transformed in Photoshop 
using the select color range function and visually identifying areas that corre-
sponded to the metachromatic particles. Photoshop was then used to gener-
ate an image depicting only those areas, which were verified visually by 
comparing the original image to the generated image. This program was not 
used to identify particles but rather to produce an outline of metachromatic 
areas with more visual contrast for viewing in journal format.
For SEM, rat peritoneal lavage cells were seeded onto polylysine-coated 
coverslips in RPMI 1640 media with 10% FBS and incubated for 15 min at 
37°C. They were then treated with compound 48/80 at 5 µg/ml for 15 min. 
Finally, the cells were fixed in 3% glutaraldehyde and processed for SEM. 
Coverslips were postfixed for one hour in 1% OsO4 (in water) before being 
dehydrated into ethanol and hexamethyldisilazane and finally dried. Then 
they were mounted and coated with osmium for imaging on a microscope 
(XL-30 ESEM-FEG; FEI Company).
Immunoblotting. For the purification of MC granule particles, rat perito-
neal cells were treated for 5 min with 5 µg/ml of compound 48/80 in a cell 
culture incubator. After the treatment, the cells were separated from granule 
particles by centrifugation at 450 g. The supernatant was carefully removed 
and thereafter spun at 12,000 g for 10 min at 4°C to pellet MC-derived par-
ticles. These were then solubilized by boiling in Laemmli buffer under re-
ducing conditions, separating the proteins by SDS-PAGE, and transferring 
to a PDVF membrane. The membrane was blocked for 1 h in 5% milk in 
TBST and then probed with an anti-TNF antibody (Santa Cruz Biotechnol-
ogy, Inc.) at 200 ng/ml at 4°C overnight. The signal was detected using en-
hanced chemiluminescence.
Microparticles.  Synthetic  heparin/chitosan  particles  were  generated  by 
gradually combining 1% heparin (EMD) and 1% chitosan (Primex; both in 
distilled H2O) in a 1:1 ratio at approximately pH 5. To produce particles, 1 vol 
of 1% chitosan was added to 5 vol of 1% heparin and vortexed for 30 s. This 
was repeated until a 1:1 ratio of 1% chitosan to 1% heparin was achieved. 
After 10 min at room temperature, the pH was then adjusted to neutrality to 
prevent further aggregation. Particles were centrifuged at 14,000 g for 10 min 
at 4°C to form a pellet and washed with water before resuspension in PBS 
for injections or water for visualization on coverslips. To load particles with 
TNF, 5 ng rTNF (R&D Systems) was vortexed for 10 min in 1.25 ml 1% 
heparin before the addition of chitosan as described in this section.
Online supplemental material. Fig. S1 shows that TNF-GFP fusion pro-
tein colocalizes with granule markers in RBL-2H3 cells. Fig. S2 shows intact 
MCs in untreated rat mesentery. Fig. S3 shows that intralymphatic MC-derived 
particle is not inside a migratory phagocyte. Fig. S4 shows that particles the 
size of MC-derived particles can enter lymphatics and rapidly reach the DLN 
under physiological conditions. Fig. S5 shows that recombinant TNF is 
gradually released from heparin-based microparticles. Video 1 shows DIC 
local effects of such complexes have been investigated. Our 
studies suggest that they may also be specialized to deliver 
their cargo of signaling proteins to far more distant targets.
MATERIALS AND METHODS
Animal studies. Rat peritoneal MCs were obtained by pooling peritoneal 
and  pleural  lavage  from  Sprague-Dawley  rats  (Taconic).  For  compound 
48/80 treatment to induce degranulation of mesenteric MCs, rats were in-
jected intraperitoneally with 0.5 mg compound 48/80 in 10 ml PBS.
C57BL/6 mice obtained from NCI were used for most mouse experi-
ments. Single footpad injections were done in a volume of 20 µl of vehicle 
in most cases. For the LN enlargement experiment, animals were injected on 
one side with the test substance and with vehicle on the other side to allow 
for within-animal controls for baseline variations in LN size.
For in vivo tracking studies, 10 µg PMA (Sigma-Aldrich) at 1 µg/µl in 
acetone or acetone alone were applied in two sequential treatments to the 
footpads of mice anesthetized with pentobarbital. Footpads were allowed to 
dry completely between applications. DLNs and footpads were harvested 
after 2 h.
For the isolation of mouse MC-derived particles, peritoneal lavage was 
performed on two to three mice using DME, and isolated cell suspensions 
were pooled and stimulated by 1 µM ionomycin (Sigma-Aldrich). Treat-
ment with ionomycin was followed by incubation for 15 min in a cell cul-
ture incubator, after which the cellular fraction was removed by two rounds 
of centrifugation at 500 g for 5 min. Exocytosed particles were then pelleted 
by spinning at 12,000 g for 10 min at 4°C. Particles were washed and resus-
pended in PBS for injection and quantification using a hemocytometer. In-
jections were performed with a 10-µl volume. For DLN hypertrophy studies, 
DLN mass was determined after 24 h as compared with a paired saline con-
trol. The saline control for DLN hypertrophy studies using isolated granules 
contained 5% DME to control for any residual media in the preparation. For 
tracking studies, KitW-sh/W-sh mice (from our breeding colony) were injected 
with isolated particles and DLNs were recovered 45 min after particle injec-
tion for sectioning and staining with toluidine blue. Images of metachro-
matic areas were generated using Photoshop (Adobe). All animal experiments 
were done according to protocols approved by the Duke University Divi-
sion of Laboratory Animal Resources and the Duke University Institutional 
Animal Care and Use Committee.
Cell culture. For the generation of TNF-GFP–expressing cells, total RNA 
was isolated from BMMCs using an RNeasy kit (QIAGEN). Complemen-
tary DNA was made using the iScript cDNA synthesis kit (Bio-Rad Labora-
tories). The tnf gene was PCR amplified using the following primers: tnf 
forward,  5-GATCTCGAGATGAGCACAGAAAGCATGATCCG-3; 
and  tnf  reverse,  5-GGTGGATCCCGCAGAGCAATGACTCCAAAG-
TAG-3. The PCR product was digested with XhoI–BamHI, and then 
ligated  with  XhoI–BamHI-digested  pLEGFP-N1  (BD)  to  generate 
pTNF-GFP. Sequence accuracy and whether TNF and GFP genes were in 
frame were confirmed by sequencing. The production of infectious viral 
particles and transfection of RBL-2H3 cell line and BMMCs were done as 
recommended by the vendor (Retroviral Gene Transfer and Expression 
User Manual; BD). In brief, the packaging cell line GP2-293 cells were 
transfected with pVSV-G (BD) and pTNF-GFP using lipofectamine 2000 
(Invitrogen). Between 48 and 72 h after transfection, viral particles were 
collected. Healthy RBL-2H3 cells were grown to 50% confluence and then 
infected by collected viral particles. The infection rate of RBL-2H3 cells was 
80–90%. BMMCs were cultured in the presence of 5 ng/ml rIL-3 (R&D 
Systems) and 5 ng/ml rSCF (R&D Systems). 2 × 105 cells/ml of healthy and 
actively dividing BMMCs were infected by the viral particles. The infection 
rate of BMMCs was around 5–10% because of the fact that these cells grow 
slowly and in suspension. The TNF-GFP–transfected cells were selected by 
adding Geneticin (Invitrogen) to a final concentration of 250 µg/ml for 5 d. 
TNF-GFP–expressing BMMCs were cultured in 5 ng/ml rIL-3 on a mono-
layer of 3T3 fibroblasts for 10 d before treatment. Both TNF-GFP–expressing 
cell types were observed after activation with 1 µM ionomycin.2466 MAST CELL PARTICLES DELIVER SIGNALS TO LYMPH NODES | Kunder et al.
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